Related Experiment Videos
Cognitive function in Japanese elderly with type 2 diabetes mellitus.
Nanaka Mogi1, Hiroyuki Umegaki, Ayako Hattori
1Department of Geriatrics, Nagoya University Graduate School of Medicine, 65 Tsuruma-Cho, Showa-Ku, Nagoya, Aichi, 466-8550, Japan.
Journal of Diabetes and Its Complications
|March 17, 2004
Summary
Japanese elderly with type 2 diabetes mellitus (DM) show poorer cognitive function, particularly those using insulin therapy. Glycemic control and insulin use significantly impact cognitive performance in this population.
Area of Science:
- Gerontology
- Endocrinology
- Neuroscience
Background:
- Type 2 diabetes mellitus (DM) is a growing concern in the elderly population.
- Cognitive impairment is a potential complication of DM, affecting quality of life.
- Limited research exists on cognitive function in Japanese elderly with DM.
Purpose of the Study:
- To investigate cognitive function in Japanese elderly individuals with type 2 DM.
- To examine the relationship between glycemic control (HbA1c) and cognitive performance.
- To assess the impact of insulin treatment on cognitive function in this demographic.
Main Methods:
- Cross-sectional study comparing 69 diabetic and 27 non-diabetic Japanese elderly (60-85 years).
- Cognitive assessments included MMSE, Word Lists Recall, Digit Symbol Test (WAIS-R), and Stroop Color Word Test.
- Glycemic control assessed via HbA1c; recent hypoglycemic episodes and insulin use were recorded.
Main Results:
- Diabetic subjects scored significantly lower on MMSE and Digit Symbol Test compared to non-diabetics.
- Digit Symbol Test scores negatively correlated with HbA1c in diabetic subjects.
- Insulin-treated diabetic subjects exhibited significantly lower MMSE and Digit Symbol Test scores than non-insulin-treated diabetics and non-diabetics.
Conclusions:
- Japanese elderly with type 2 DM exhibit impaired cognitive function.
- Insulin treatment in elderly diabetic patients is associated with poorer cognitive outcomes.
- Glycemic control and insulin therapy are critical factors influencing cognitive health in elderly diabetics.